Live from the NIH registry
Studies recruiting near Waco right now
Top 25 of 53 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Waco, Texas (2.6 mi)
· Sponsor: GlaxoSmithKline
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
ActiveTherapy Alliance — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Waco, Texas (2.6 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: 89bio, Inc.
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Nextstage Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Digestive Research of Central Texas — Waco, Texas (2.6 mi)
· Sponsor: Eccogene
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Type 2 Diabetes
Phase 2
Interventional 300 participants sought
Velocity Clinical Research Waco — Waco, Texas (2.6 mi)
· Sponsor: Housey Healthcare ULC
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Waco, Texas (2.6 mi)
· Sponsor: 89bio, Inc.
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Primary Biliary Cholangitis (PBC)
Phase 3
Interventional 276 participants sought
Impact Research Tx — Waco, Texas (2.6 mi)
· Sponsor: Ipsen
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
Post-operative Pain Management
N/A
Interventional 148 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: University of California, Los Angeles
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Primary Biliary Cholangitis, PBC
Phase 2
Interventional 260 participants sought
Impact Research — Waco, Texas (2.6 mi)
· Sponsor: Mirum Pharmaceuticals, Inc.
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Phase 3
Interventional 1,590 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
Multi-analyte Blood Test Clinical Trial
Liver Cirrhosis, Liver Cancer
N/A
Observational 1,200 participants sought
Impact Research Institute — Waco, Texas (2.6 mi)
· Sponsor: Helio Genomics
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Waco — Waco, Texas (2.6 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Waco, Texas (2.6 mi)
· Sponsor: AstraZeneca
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 8618 — Waco, Texas (2.6 mi)
· Sponsor: Galderma R&D
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Velocity Clinical Research, Waco — Waco, Texas (2.6 mi)
· Sponsor: Boehringer Ingelheim
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Texas Oncology - Waco — Waco, Texas (2.6 mi)
· Sponsor: Agendia
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma
Phase 1, Phase 2
Interventional 224 participants sought
Texas Oncology - Central South — Waco, Texas (2.6 mi)
· Sponsor: Pfizer
Reliability and Validity of the PReFS
Neurologic Disorders, Spinal Cord Injury
N/A
Observational 15 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: Baylor University
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 1060 — Waco, Texas (2.6 mi)
· Sponsor: Anthos Therapeutics, Inc.
Alleviant ALLAY-HF Study
Heart Failure
N/A
Interventional 700 participants sought
Waco Cardiology — Waco, Texas (2.6 mi)
· Sponsor: Alleviant Medical, Inc.
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Phase 2
Interventional 92 participants sought
Digestive Research of Central Texas, LLC — Waco, Texas (2.6 mi)
· Sponsor: Chugai Pharmaceutical
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Non-small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Phase 1
Interventional 350 participants sought
USOR - Texas Oncology - (DFW) Waco — Waco, Texas (2.6 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Paper-Based and Smartphone-Based Memory Supports
Alzheimer Disease, Dementia, Mild
N/A
Interventional 200 participants sought
Baylor University — Waco, Texas (2.6 mi)
· Sponsor: Baylor University